As of 3:59pm ET
| +0.05 / +1.43%|
The 2 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a -1.41% decrease from the last price of 3.55.
The current consensus among 4 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.